tiprankstipranks
Trending News
More News >
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market
Advertisement

Neurosense Therapeutics Ltd. (NRSN) Revenue

Compare
166 Followers

Neurosense Therapeutics Ltd. Revenue

Neurosense Therapeutics Ltd. had a revenue of 0.00 in the quarter ending Sep 30, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Neurosense Therapeutics Ltd. had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
17
Market Cap
$29.03M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00%
Dec 31, 2023
0.00%
Dec 31, 2022
0.00%
Dec 31, 2021
0.00%
Dec 31, 2020
0.00%
Dec 31, 2019
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis